Medtech
Custom surgical implant startup using AI lands 96 investors for $12M in new cash
When medical device startup Restor3d went to market to find new funding – minimum investment of $25,000 required – it found plenty of takers. Here are…
RESEARCH TRIANGLE PARK – When medical device startup Restor3d went to market to find new funding – minimum investment of $25,000 required – it found plenty of takers.
In fact, 96 backers signed on to secure part of Restore3D’s $12 million debt and convertible note offering.
The funding was disclosed in an SEC filing made Wednesday and signed by CEO Kurt Jacobus.
wants to make the surgical process more personal – and more effective.
The RTP-headquartered company is using 3D printing, artificial intelligence (AI), and machine learning (ML) to design patient-specific surgical implants and related instruments across multiple fields of medicine, reports Bryant Haskins for the N.C. Biotech Center.
Since its creation in 2017, the company – originally known as Additive Device – has concentrated on developing 3D printed medical devices, created with advanced biomaterials, and designed specifically for the patients who receive them, Haskins wrote.
Prior to the debt financing Restore3D had raised nearly $24 million from investors.
Custom surgical implants: 3D printing plus AI is tech behind RTP startup restor3D
The post Custom surgical implant startup using AI lands 96 investors for $12M in new cash first appeared on WRAL TechWire.
implant
medicine
medical
device
devices
artificial intelligence
ai
machine learning
ETF Talk: AI is ‘Big Generator’
Second nature comes alive Even if you close your eyes We exist through this strange device — Yes, “Big Generator” Artificial intelligence (AI) has…
Apple gets an appeals court win for its Apple Watch
Apple has at least a couple more weeks before it has to worry about another sales ban.
Federal court blocks ban on Apple Watches after Apple appeal
A federal appeals court has temporarily blocked a sweeping import ban on Apple’s latest smartwatches while the patent dispute winds its way through…